KIF11 as a potential cancer prognostic marker promotes tumorigenesis in children with Wilms tumor

Luo, Yishu; Liu, Wei; Zhu, Yiyong; Tian, Yongshen; Wu, Ke; Ji, Linghua; Ding, Li; Zhang, Wenwen; Gao, Tingting; Liu, Xiaoqin; Zhao, Jun

doi:10.1080/08880018.2021.1953655

Cited by 4 publications

(1 citation statement)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The relationship between vascular endothelial growth factor expression and the risk of childhood nephroblastoma: systematic review and meta-analysis clinically rare malignant kidney tumor, with an incidence of less than 3%. AWT has a high degree of malignancy, rapid growth, early metastasis, difficult preoperative diagnosis, and high misdiagnosis rate (5). Tumorigenesis may involve WT1 (Wilms Tumor suppressor gene), WT2, P53 and other genes, and may also be related to congenital genetic factors.…”

Section: Original Articlementioning

confidence: 99%

The relationship between vascular endothelial growth factor expression and the risk of childhood nephroblastoma: systematic review and meta-analysis

Liao¹,

Zhu²,

Zhang³

et al. 2022

Transl Pediatr

View full text Add to dashboard Cite

Background: This study explores the correlation between vascular endothelial growth factor expression and the risk of childhood nephroblastoma.Methods: PubMed, Embase, Cochrane Library, China National Knowledge Infrastructure (CNKI), Wanfang database were searched to collect independent study data published in China between 2010 and 2021 on the expression and significance of VEGF in childhood nephroblastoma, and literature heterogeneity was tested. The odds ratio (OR) value was used as the effect indicator. Meta-analysis software RevMan 4.2.2 was used, and the original data of each study were statistically processed to calculate the combined OR value and 95% confidence interval (CI).Results: Twelve studies involving 1,226 cases of pediatric nephroblastoma were included for systematic evaluation. The 12 randomized controlled studies reported the expression of VEGF in childhood nephroblastoma (OR =9.06, 95% CI: 6.97-11.78, P<0.00001). There was a statistically significant difference in expression of VEGF between the unfavorable histology (UH) group and the favorable histology (FH) group (OR =1.17, 95% CI: 1.07-1.27, P=0.0006) and expression of VEGF in different clinical stages of nephroblastoma, including stage I-II and III-IV (OR =0.49, 95% CI: 0.42-0.58, P<0.00001). Positive expression of VEGF showed no significant statistical difference between cases with and without tumor metastasis (OR =1.08, 95% CI: 0.86-1.36, P=0.50). Conclusions:The expression of VEGF may play an important role in the occurrence and development of childhood nephroblastoma and could help guide clinicians to judge disease and treatment.

show abstract

Section: Original Articlementioning

confidence: 99%